Mucosal vaccination: lung versus nose.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 21492942)

Published in Vet Immunol Immunopathol on March 23, 2011

Authors

Ana Vujanic1, Philip Sutton, Kenneth J Snibson, Hung-Hsun Yen, Jean-Pierre Y Scheerlinck

Author Affiliations

1: Centre for Animal Biotechnology, Faculty of Veterinary Science, The University of Melbourne, Parkville 3010, Victoria, Australia.

Articles by these authors

Mucin dynamics and enteric pathogens. Nat Rev Microbiol (2011) 4.23

MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog (2009) 1.69

Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology (2007) 1.43

Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Vet Immunol Immunopathol (2008) 1.36

Biomedical applications of sheep models: from asthma to vaccines. Trends Biotechnol (2008) 1.24

White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res (2002) 1.23

The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut (2011) 1.13

Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci U S A (2003) 1.10

Localized suppression of inflammation at sites of Helicobacter pylori colonization. Infect Immun (2011) 0.98

Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. Hepatology (2012) 0.97

Thoracic duct cannulation without thoracotomy in sheep: a method for accessing efferent lymph from the lung. Vet Immunol Immunopathol (2008) 0.95

Saponin-adjuvanted particulate vaccines for clinical use. Methods (2006) 0.95

Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX adjuvanted recombinant antigens. Vaccine (2010) 0.92

M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens. Infect Immun (2009) 0.91

Chronic endotoxin exposure causes brain injury in the ovine fetus in the absence of hypoxemia. J Soc Gynecol Investig (2006) 0.89

Chronic airway disease: deteriorating pulmonary function in sheep associated with repeated challenges of house dust mite. Exp Lung Res (2006) 0.89

Cellular and molecular characterisation of the ovine rectal mucosal environment. Vet Immunol Immunopathol (2002) 0.88

Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine. Clin Vaccine Immunol (2011) 0.87

Helicobacter pylori defense against oxidative attack. Am J Physiol Gastrointest Liver Physiol (2011) 0.86

Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology (2009) 0.85

Airway disease: the use of large animal models for drug discovery. Pulm Pharmacol Ther (2011) 0.85

Helicobacter pylori thiolperoxidase as a protective antigen in single- and multi-component vaccines. Vaccine (2012) 0.84

Muc1 limits Helicobacter felis binding to gastric epithelial cells but does not limit colonization and gastric pathology following infection. Helicobacter (2008) 0.84

Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression. J Clin Invest (2016) 0.83

Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2. Arthritis Rheumatol (2015) 0.83

Vaccinating against Helicobacter pylori: dissecting the mechanism. Gastroenterology (2011) 0.82

Gene gun immunization in a preclinical model is enhanced by B7 targeting. Vaccine (2003) 0.82

Effects of implantation and early pregnancy on the expression of cytokines and vascular surface molecules in the sheep endometrium. J Reprod Immunol (2004) 0.81

Immunogenicity and pathogenicity of Helicobacter infections of veterinary animals. Vet Immunol Immunopathol (2008) 0.81

A sheep cannulation model for evaluation of nasal vaccine delivery. Methods (2006) 0.80

Measurement and impact of remodeling in the lung: airway neovascularization in asthma. Proc Am Thorac Soc (2009) 0.79

PAR-1 polymorphisms and risk of Helicobacter pylori-related gastric cancer in a Chinese population. Anticancer Res (2012) 0.79

Activin A: from sometime reproductive factor to genuine cytokine. Vet Immunol Immunopathol (2005) 0.78

Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation. Vaccine (2006) 0.78

Helicobacter pylori flagella: antigenic profile and protective immunity. FEMS Immunol Med Microbiol (2007) 0.78

Inflammatory cytokines IL-6 and TNF-α regulate lymphocyte trafficking through the local lymph node. Vet Immunol Immunopathol (2011) 0.78

Advances in mucosal vaccination. Anim Health Res Rev (2004) 0.78

Biological activity of ovine IL-23 expressed using a foot-and-mouth disease virus 2A self-cleaving peptide. Cytokine (2013) 0.78

Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol (2005) 0.78

Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen. Vaccine (2010) 0.78

Phenotypic analysis of ovine antigen presenting cells loaded with nanoparticles migrating from the site of vaccination. Methods (2013) 0.77

Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads. Vaccine (2008) 0.77

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori. Vaccine (2008) 0.77

Biodegradable and biocompatible poly(ethylene glycol)-based hydrogel films for the regeneration of corneal endothelium. Adv Healthc Mater (2014) 0.77

Veterinary applications of cytokines. Vet Immunol Immunopathol (2005) 0.77

Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression. Helicobacter (2013) 0.77

A comparison of glycan expression and adhesion of mouse-adapted strains and clinical isolates of Helicobacter pylori. FEMS Immunol Med Microbiol (2009) 0.76

Did transmission of Helicobacter pylori from humans cause a disease outbreak in a colony of Stripe-faced Dunnarts (Sminthopsis macroura)? Vet Res (2011) 0.76

Targeting of whole killed bacteria to gastrointestinal M-cells induces humoral immunity in the female reproductive tract. Gut Microbes (2010) 0.76

Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep. Vet Immunol Immunopathol (2013) 0.76

ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza. Hum Vaccin Immunother (2015) 0.75

Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge. Helicobacter (2008) 0.75

Defining immune memory resilience: implications for vaccine development. Expert Rev Vaccines (2010) 0.75

Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity. Inflamm Bowel Dis (2017) 0.75

Observations of sacrocaudal fusion in Greyhounds and other dogs. Vet Comp Orthop Traumatol (2015) 0.75

Local immune responses following nasal delivery of an adjuvanted influenza vaccine. Vaccine (2006) 0.75

Increased Helicobacter felis colonization in male 129/Sv mice fails to suppress gastritis. Gut Microbes (2011) 0.75

Mucosal immunology down under: Special Interest Group in Mucosal Immunology workshop, Australasian Society for Immunology, Sydney, Australia, 2 December 2007. Immunol Cell Biol (2008) 0.75

Exploring local immune responses to vaccines using efferent lymphatic cannulation. Expert Rev Vaccines (2015) 0.75

Mouse models of Helicobacter-induced gastric cancer: use of cocarcinogens. Methods Mol Biol (2012) 0.75